Vulnerability record · CVE-2023-33365 · published 3 August 2023
CVE-2023-33365: Supremainc biostar 2 path traversal vulnerability
Supremainc · Biostar 2
A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.
Description
A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Affected products
1 vulnerable configurations from NVD's CPE data, grouped by vendor and product.
References
| Link | Tags |
|---|---|
| https://claroty.com/team82/disclosure-dashboard/cve-2023-33365 | Third Party Advisory |
| https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291 | Release NotesVendor Advisory |
| https://claroty.com/team82/disclosure-dashboard/cve-2023-33365 | Third Party Advisory |
| https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291 | Release NotesVendor Advisory |
Track CVE-2023-33365 inside VULONE
Watch it alongside the ransomware crews, C2 infrastructure and forum chatter that reference it, query it through the API and pull it into your SIEM over TAXII.
Related vulnerabilities
Same products first, then exploited flaws of the same weakness class.
Source: NIST National Vulnerability Database (record CVE-2023-33365), CISA KEV, FIRST EPSS (scores of 2026-09-26). This page is refreshed as NVD updates the record.